search
Back to results

Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart Disease (LVH)

Primary Purpose

Lv Hypertrophy, Heart Failure, Diastolic, Stiffness, Vascular

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
High intensity exercise
Yoga
Sponsored by
University of Texas Southwestern Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lv Hypertrophy focused on measuring LVH, Ventricular Stiffness, Fitness, HFpEF

Eligibility Criteria

40 Years - 64 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Presence of left ventricular hypertrophy (by MRI, echocardiography or ECG)
  • Normal ejection fraction (>50%)
  • Elevated cardiac biomarker (high sensitivity troponin, NT-BNP)

Exclusion Criteria:

  • age < 40 or >64
  • body mass index>35
  • history of heart failure, myocarditis, restrictive cardiomyopathy, severe chronic obstructive pulmonary disease, unstable coronary artery disease or recent (<12 month) acute coronary syndrome, cerebrovascular disease as evidenced by prior transient ischemic attack or stroke and active/recent tobacco use (quit < 5 years).
  • chronic orthopedic injury that precludes exercise testing

Sites / Locations

  • The Institute for Exercise and Environmental Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

High Intensity Exercise

Yoga

Arm Description

Subjects randomized to receive high intensity aerobic exercise will undergo exercise training for 1 year. A training program will be developed individually for each subject with the goal of increasing duration and intensity consistent with exercise training principles. Workouts will vary with respect to mode (walk, cycle) and duration (30 - 60 minutes). Each subject will be assigned an exercise physiologist and a heart rate monitor so that each session can be tracked and recorded.

Subjects randomized to yoga will receive instructions on strength and flexibility exercises.

Outcomes

Primary Outcome Measures

Left ventricular stiffness
Change in ventricular stiffness after 1 year of exercise training measured as the stiffness constant of the diastolic limb of the left ventricular pressure-volume curve

Secondary Outcome Measures

Aerobic fitness
Change in peak aerobic capacity (VO2) after 1 year of exercise training
Vascular stiffness
Change in pulse wave velocity after 1 year of exercise training

Full Information

First Posted
March 1, 2018
Last Updated
October 10, 2019
Sponsor
University of Texas Southwestern Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03476785
Brief Title
Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart Disease
Acronym
LVH
Official Title
Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart Disease
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Completed
Study Start Date
June 1, 2015 (Actual)
Primary Completion Date
July 2, 2019 (Actual)
Study Completion Date
July 2, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Texas Southwestern Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether vigorous exercise training 4-5 days/week for one year in sedentary middle aged (ages 40-64) individuals at high risk for future development of heart failure will improve cardiac and vascular compliance to a degree equivalent to life-long exercisers and the sedentary young. To date, no effective therapy for heart failure with preserved ejection fraction (HFpEF) has been found; therefore prevention is critical and discovering novel treatment strategies is essential. Exercise training if implemented in high risk patients may improve diastolic function and cardiac-vascular interactions, preventing further progression to overt heart failure.
Detailed Description
The global objective of this project is to test novel strategies to prevent diastolic dysfunction associated with HFpEF; these include: a) identifying high risk individuals by using population derived imaging and blood biomarkers; and b) implementing novel exercise training strategies in these middle age individuals, when cardiac plasticity still exists, to forestall the development of diastolic abnormalities that progress to HFpEF. Prior research has demonstrated that: a) healthy but sedentary aging leads to atrophy and stiffening of the heart with reduced myocardial and chamber compliance; b) in contrast, highly competitive senior athletes had cardiac compliance that was indistinguishable from healthy young individuals suggesting that lifelong exercise training prevented this stiffening; c) even prolonged and intense exercise training started after age 65 failed to reverse age-related cardiac and vascular stiffening; d) cardiac stiffening begins in middle age (40-64) and can be substantially prevented by training 4-5 days/wk. The primary objective of this project is therefore to identify high risk sedentary individuals age 40-64, and initiate an exercise program carefully designed to maximize effects on cardiovascular compliance and function. Findings from this aim would have enormous public health significance and establish a novel, practical exercise training strategy designed to reverse cardiovascular stiffening. Hypothesis: Exercise training, when implemented 4-5 times/week over a prolonged period of time in sedentary high risk middle aged men and women, age 40-64 will improve cardiac and vascular compliance to a degree equivalent to life-long exercisers (and sedentary young); Specific Aim: To test the hypothesis, two groups of previously sedentary subjects, ages 40-64 at particularly high risk for HF will be studied for one year, with the following interventions: 1) subjects undergoing prolonged endurance/interval/strength exercise training; and 2) strength and flexibility /balance control. Subjects will be categorized as high risk and enrolled on the basis of elevated serum biomarkers and left ventricular hypertrophy (LVH) documented by cardiac MRI. Comprehensive invasive and non-invasive assessment of cardiovascular structure and systolic/diastolic function will be performed before and after 1 year of an exercise intervention involving high intensity aerobic intervals, lower intensity endurance training, and strength training, compared with strength and flexibility control.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lv Hypertrophy, Heart Failure, Diastolic, Stiffness, Vascular
Keywords
LVH, Ventricular Stiffness, Fitness, HFpEF

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
Outcomes assessor will be blinded to subject randomization.
Allocation
Randomized
Enrollment
56 (Actual)

8. Arms, Groups, and Interventions

Arm Title
High Intensity Exercise
Arm Type
Experimental
Arm Description
Subjects randomized to receive high intensity aerobic exercise will undergo exercise training for 1 year. A training program will be developed individually for each subject with the goal of increasing duration and intensity consistent with exercise training principles. Workouts will vary with respect to mode (walk, cycle) and duration (30 - 60 minutes). Each subject will be assigned an exercise physiologist and a heart rate monitor so that each session can be tracked and recorded.
Arm Title
Yoga
Arm Type
Placebo Comparator
Arm Description
Subjects randomized to yoga will receive instructions on strength and flexibility exercises.
Intervention Type
Behavioral
Intervention Name(s)
High intensity exercise
Intervention Description
Subjects will perform high intensity aerobic exercise in addition to moderate intensity sessions 4-5 times per week.
Intervention Type
Behavioral
Intervention Name(s)
Yoga
Intervention Description
Subjects will perform strength and flexibility exercises.
Primary Outcome Measure Information:
Title
Left ventricular stiffness
Description
Change in ventricular stiffness after 1 year of exercise training measured as the stiffness constant of the diastolic limb of the left ventricular pressure-volume curve
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Aerobic fitness
Description
Change in peak aerobic capacity (VO2) after 1 year of exercise training
Time Frame
1 year
Title
Vascular stiffness
Description
Change in pulse wave velocity after 1 year of exercise training
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Presence of left ventricular hypertrophy (by MRI, echocardiography or ECG) Normal ejection fraction (>50%) Elevated cardiac biomarker (high sensitivity troponin, NT-BNP) Exclusion Criteria: age < 40 or >64 body mass index>35 history of heart failure, myocarditis, restrictive cardiomyopathy, severe chronic obstructive pulmonary disease, unstable coronary artery disease or recent (<12 month) acute coronary syndrome, cerebrovascular disease as evidenced by prior transient ischemic attack or stroke and active/recent tobacco use (quit < 5 years). chronic orthopedic injury that precludes exercise testing
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Benjamin D Levine, MD
Organizational Affiliation
University of Texas Southwestern Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Institute for Exercise and Environmental Medicine
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
34543068
Citation
Hieda M, Sarma S, Hearon CM Jr, MacNamara JP, Dias KA, Samels M, Palmer D, Livingston S, Morris M, Levine BD. One-Year Committed Exercise Training Reverses Abnormal Left Ventricular Myocardial Stiffness in Patients With Stage B Heart Failure With Preserved Ejection Fraction. Circulation. 2021 Sep 21;144(12):934-946. doi: 10.1161/CIRCULATIONAHA.121.054117. Epub 2021 Sep 20.
Results Reference
derived
PubMed Identifier
31865771
Citation
Hieda M, Sarma S, Hearon CM Jr, Dias KA, Martinez J, Samels M, Everding B, Palmer D, Livingston S, Morris M, Howden E, Levine BD. Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction. Circulation. 2020 Jan 14;141(2):115-123. doi: 10.1161/CIRCULATIONAHA.119.040332. Epub 2019 Dec 23.
Results Reference
derived

Learn more about this trial

Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart Disease

We'll reach out to this number within 24 hrs